Banks - Regional
Compare Stocks
5 / 10Stock Comparison
FRST vs NBTB vs UVSP vs CZWI vs MNSB
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Regional
FRST vs NBTB vs UVSP vs CZWI vs MNSB — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional |
| Market Cap | $360M | $2.35B | $1.10B | $203M | $176M |
| Revenue (TTM) | $313M | $867M | $518M | $90M | $136M |
| Net Income (TTM) | $61M | $169M | $91M | $14M | $16M |
| Gross Margin | 67.6% | 72.1% | 61.0% | 54.7% | 54.4% |
| Operating Margin | 23.2% | 25.3% | 21.9% | 7.0% | 14.0% |
| Forward P/E | 9.1x | 10.8x | 11.1x | 11.8x | 10.4x |
| Total Debt | $262M | $327M | $352M | $52M | $70M |
| Cash & Equiv. | $144M | $185M | $554M | $119M | $25M |
FRST vs NBTB vs UVSP vs CZWI vs MNSB — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Primis Financial Co… (FRST) | 100 | 145.0 | +45.0% |
| NBT Bancorp Inc. (NBTB) | 100 | 143.9 | +43.9% |
| Univest Financial C… (UVSP) | 100 | 234.7 | +134.7% |
| Citizens Community … (CZWI) | 100 | 286.8 | +186.8% |
| MainStreet Bancshar… (MNSB) | 100 | 177.2 | +77.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FRST vs NBTB vs UVSP vs CZWI vs MNSB
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FRST carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.
- Rev growth 23.0%, EPS growth 477.3%
- PEG 0.43 vs CZWI's 2.32
- 23.0% NII/revenue growth vs CZWI's -9.4%
- Lower P/E (9.1x vs 11.8x), PEG 0.43 vs 2.32
NBTB ranks third and is worth considering specifically for income & stability.
- Dividend streak 12 yrs, beta 0.89, yield 3.2%
- 3.2% yield, 12-year raise streak, vs CZWI's 1.8%, (1 stock pays no dividend)
UVSP is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- Efficiency ratio 0.4% vs CZWI's 0.5% (lower = leaner)
- Efficiency ratio 0.4% vs CZWI's 0.5%
CZWI is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 157.0% 10Y total return vs UVSP's 140.1%
- Lower volatility, beta 0.46, Low D/E 27.6%, current ratio 3015.31x
- Beta 0.46, yield 1.8%, current ratio 3015.31x
- Beta 0.46 vs UVSP's 1.01, lower leverage
MNSB is the clearest fit if your priority is bank quality.
- NIM 3.1% vs FRST's 2.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 23.0% NII/revenue growth vs CZWI's -9.4% | |
| Value | Lower P/E (9.1x vs 11.8x), PEG 0.43 vs 2.32 | |
| Quality / Margins | Efficiency ratio 0.4% vs CZWI's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.46 vs UVSP's 1.01, lower leverage | |
| Dividends | 3.2% yield, 12-year raise streak, vs CZWI's 1.8%, (1 stock pays no dividend) | |
| Momentum (1Y) | +72.1% vs NBTB's +9.0% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs CZWI's 0.5% |
FRST vs NBTB vs UVSP vs CZWI vs MNSB — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FRST vs NBTB vs UVSP vs CZWI vs MNSB — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NBTB leads in 2 of 6 categories
FRST leads 1 • CZWI leads 1 • UVSP leads 0 • MNSB leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NBTB leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
NBTB is the larger business by revenue, generating $867M annually — 9.6x CZWI's $90M. FRST is the more profitable business, keeping 19.7% of every revenue dollar as net income compared to MNSB's 11.5%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $313M | $867M | $518M | $90M | $136M |
| EBITDAEarnings before interest/tax | $79M | $241M | $119M | $9M | $23M |
| Net IncomeAfter-tax profit | $61M | $169M | $91M | $14M | $16M |
| Free Cash FlowCash after capex | $9M | $225M | $92M | $11M | $13M |
| Gross MarginGross profit ÷ Revenue | +67.6% | +72.1% | +61.0% | +54.7% | +54.4% |
| Operating MarginEBIT ÷ Revenue | +23.2% | +25.3% | +21.9% | +7.0% | +14.0% |
| Net MarginNet income ÷ Revenue | +19.7% | +19.5% | +17.5% | +16.0% | +11.5% |
| FCF MarginFCF ÷ Revenue | +2.9% | +25.2% | +18.7% | +11.5% | +7.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +2.3% | +39.5% | +23.1% | +63.0% | +120.9% |
Valuation Metrics
FRST leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 5.9x trailing earnings, FRST trades at a 59% valuation discount to CZWI's 14.4x P/E. Adjusting for growth (PEG ratio), FRST offers better value at 0.28x vs CZWI's 2.85x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $360M | $2.4B | $1.1B | $203M | $176M |
| Enterprise ValueMkt cap + debt − cash | $479M | $2.5B | $897M | $136M | $221M |
| Trailing P/EPrice ÷ TTM EPS | 5.86x | 13.53x | 12.21x | 14.44x | 13.36x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.10x | 10.80x | 11.10x | 11.78x | 10.45x |
| PEG RatioP/E ÷ EPS growth rate | 0.28x | 1.92x | 0.84x | 2.85x | — |
| EV / EBITDAEnterprise value multiple | 6.60x | 10.35x | 7.49x | 15.28x | 11.58x |
| Price / SalesMarket cap ÷ Revenue | 1.15x | 2.71x | 2.12x | 2.25x | 1.30x |
| Price / BookPrice ÷ Book value/share | 0.85x | 1.21x | 1.18x | 1.09x | 0.82x |
| Price / FCFMarket cap ÷ FCF | 39.89x | 10.75x | 11.34x | 19.55x | 16.57x |
Profitability & Efficiency
Evenly matched — FRST and NBTB and UVSP each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
FRST delivers a 15.8% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $7 for MNSB. NBTB carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to FRST's 0.62x. On the Piotroski fundamental quality scale (0–9), NBTB scores 7/9 vs MNSB's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +15.8% | +9.5% | +9.8% | +7.8% | +7.3% |
| ROA (TTM)Return on assets | +1.6% | +1.1% | +1.1% | +0.8% | +0.7% |
| ROICReturn on invested capital | +9.2% | +7.9% | +6.5% | +2.0% | +5.0% |
| ROCEReturn on capital employed | +6.1% | +2.4% | +8.8% | +0.6% | +0.9% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 7 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.62x | 0.17x | 0.37x | 0.28x | 0.32x |
| Net DebtTotal debt minus cash | $119M | $142M | -$202M | -$67M | $45M |
| Cash & Equiv.Liquid assets | $144M | $185M | $554M | $119M | $25M |
| Total DebtShort + long-term debt | $262M | $327M | $352M | $52M | $70M |
| Interest CoverageEBIT ÷ Interest expense | 0.82x | 1.05x | 0.60x | 0.16x | 0.31x |
Total Returns (Dividends Reinvested)
CZWI leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CZWI five years ago would be worth $17,124 today (with dividends reinvested), compared to $11,317 for FRST. Over the past 12 months, FRST leads with a +72.1% total return vs NBTB's +9.0%. The 3-year compound annual growth rate (CAGR) favors CZWI at 37.5% vs MNSB's 6.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +12.6% | +9.3% | +20.9% | +21.5% | +19.4% |
| 1-Year ReturnPast 12 months | +72.1% | +9.0% | +32.0% | +45.6% | +26.4% |
| 3-Year ReturnCumulative with dividends | +116.0% | +54.1% | +137.1% | +160.0% | +21.5% |
| 5-Year ReturnCumulative with dividends | +13.2% | +29.9% | +46.4% | +71.2% | +20.6% |
| 10-Year ReturnCumulative with dividends | +52.1% | +102.2% | +140.1% | +157.0% | +126.9% |
| CAGR (3Y)Annualised 3-year return | +29.3% | +15.5% | +33.4% | +37.5% | +6.7% |
Risk & Volatility
Evenly matched — UVSP and CZWI each lead in 1 of 2 comparable metrics.
Risk & Volatility
CZWI is the less volatile stock with a 0.46 beta — it tends to amplify market swings less than UVSP's 1.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UVSP currently trades 98.8% from its 52-week high vs CZWI's 93.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.87x | 0.89x | 1.01x | 0.46x | 0.66x |
| 52-Week HighHighest price in past year | $14.97 | $46.92 | $39.06 | $22.62 | $25.17 |
| 52-Week LowLowest price in past year | $8.69 | $39.20 | $27.91 | $12.83 | $17.86 |
| % of 52W HighCurrent price vs 52-week peak | +97.5% | +96.1% | +98.8% | +93.2% | +93.4% |
| RSI (14)Momentum oscillator 0–100 | 64.9 | 57.3 | 68.1 | 63.7 | 50.4 |
| Avg Volume (50D)Average daily shares traded | 191K | 236K | 180K | 40K | 58K |
Analyst Outlook
NBTB leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: FRST as "Buy", NBTB as "Hold", UVSP as "Hold", CZWI as "Buy", MNSB as "Hold". Consensus price targets imply 2.1% upside for NBTB (target: $46) vs -11.9% for UVSP (target: $34). For income investors, NBTB offers the higher dividend yield at 3.17% vs CZWI's 1.76%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | $14.00 | $46.00 | $34.00 | — | — |
| # AnalystsCovering analysts | 2 | 10 | 6 | 2 | 1 |
| Dividend YieldAnnual dividend ÷ price | +2.7% | +3.2% | +2.3% | +1.8% | — |
| Dividend StreakConsecutive years of raises | 0 | 12 | 1 | 7 | 2 |
| Dividend / ShareAnnual DPS | $0.40 | $1.43 | $0.88 | $0.37 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +0.4% | +3.2% | +3.1% | 0.0% |
NBTB leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). FRST leads in 1 (Valuation Metrics). 2 tied.
FRST vs NBTB vs UVSP vs CZWI vs MNSB: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FRST or NBTB or UVSP or CZWI or MNSB a better buy right now?
For growth investors, Primis Financial Corp.
(FRST) is the stronger pick with 23. 0% revenue growth year-over-year, versus -9. 4% for Citizens Community Bancorp, Inc. (CZWI). Primis Financial Corp. (FRST) offers the better valuation at 5. 9x trailing P/E (9. 1x forward), making it the more compelling value choice. Analysts rate Primis Financial Corp. (FRST) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FRST or NBTB or UVSP or CZWI or MNSB?
On trailing P/E, Primis Financial Corp.
(FRST) is the cheapest at 5. 9x versus Citizens Community Bancorp, Inc. at 14. 4x. On forward P/E, Primis Financial Corp. is actually cheaper at 9. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Primis Financial Corp. wins at 0. 43x versus Citizens Community Bancorp, Inc. 's 2. 32x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — FRST or NBTB or UVSP or CZWI or MNSB?
Over the past 5 years, Citizens Community Bancorp, Inc.
(CZWI) delivered a total return of +71. 2%, compared to +13. 2% for Primis Financial Corp. (FRST). Over 10 years, the gap is even starker: CZWI returned +157. 0% versus FRST's +52. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FRST or NBTB or UVSP or CZWI or MNSB?
By beta (market sensitivity over 5 years), Citizens Community Bancorp, Inc.
(CZWI) is the lower-risk stock at 0. 46β versus Univest Financial Corporation's 1. 01β — meaning UVSP is approximately 121% more volatile than CZWI relative to the S&P 500. On balance sheet safety, NBT Bancorp Inc. (NBTB) carries a lower debt/equity ratio of 17% versus 62% for Primis Financial Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — FRST or NBTB or UVSP or CZWI or MNSB?
By revenue growth (latest reported year), Primis Financial Corp.
(FRST) is pulling ahead at 23. 0% versus -9. 4% for Citizens Community Bancorp, Inc. (CZWI). On earnings-per-share growth, the picture is similar: Primis Financial Corp. grew EPS 477. 3% year-over-year, compared to 9. 0% for Citizens Community Bancorp, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FRST or NBTB or UVSP or CZWI or MNSB?
Primis Financial Corp.
(FRST) is the more profitable company, earning 19. 7% net margin versus 11. 5% for MainStreet Bancshares, Inc. — meaning it keeps 19. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NBTB leads at 25. 3% versus 7. 0% for CZWI. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FRST or NBTB or UVSP or CZWI or MNSB more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Primis Financial Corp. (FRST) is the more undervalued stock at a PEG of 0. 43x versus Citizens Community Bancorp, Inc. 's 2. 32x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Primis Financial Corp. (FRST) trades at 9. 1x forward P/E versus 11. 8x for Citizens Community Bancorp, Inc. — 2. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NBTB: 2. 1% to $46. 00.
08Which pays a better dividend — FRST or NBTB or UVSP or CZWI or MNSB?
In this comparison, NBTB (3.
2% yield), FRST (2. 7% yield), UVSP (2. 3% yield), CZWI (1. 8% yield) pay a dividend. MNSB does not pay a meaningful dividend and should not be held primarily for income.
09Is FRST or NBTB or UVSP or CZWI or MNSB better for a retirement portfolio?
For long-horizon retirement investors, Citizens Community Bancorp, Inc.
(CZWI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 46), 1. 8% yield, +157. 0% 10Y return). Both have compounded well over 10 years (CZWI: +157. 0%, MNSB: +126. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FRST and NBTB and UVSP and CZWI and MNSB?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: FRST is a small-cap high-growth stock; NBTB is a small-cap deep-value stock; UVSP is a small-cap deep-value stock; CZWI is a small-cap deep-value stock; MNSB is a small-cap deep-value stock. FRST, NBTB, UVSP, CZWI pay a dividend while MNSB does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.